Resource-limited countries bear the highest burden of HCV infection. In the era of new highly effective HCV drugs—and from a global health perspective—strategies to scale up treatment in these countries are urgently needed. However, numerous gaps must be filled to make these strategies feasible and effective.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 57, 1333–1342 (2013).
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. & Bell, B. P. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45, 529–538 (2006).
Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T. & Jennings, L. W. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, 513–521 (2010).
Obach, D. et al. How to optimize HCV treatment impact on life years saved in resource-constrained countries. Hepatology http://dx.doi.org/10.1002/hep.27691.
Hill, A., Khoo, S., Fortunak, J., Simmons, B. & Ford, N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin. Infect. Dis. 58, 928–936 (2014).
Lemoine, M. & Thursz, M. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas. Semin. Liver Dis. 34, 89–97 (2014).
Lemoine, M., Eholie, S. & Lacombe, K. Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach. J. Hepatol. 62, 469–476 (2015).
WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection. WHO[online] (2014).
El-Zanaty, F. & Way, A. Egypt: Demographic and Health Survey 2008. Demographic and Healthy Surveys [online], (2008).
Thomas, D. L. Cure of hepatitis C virus infection without interferon alfa: scientific basis and current clinical evidence. Top. Antivir. Med. 21, 152–156 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Lemoine, M., Thursz, M. Scaling up HCV treatment in resource-limited countries. Nat Rev Gastroenterol Hepatol 12, 193–194 (2015). https://doi.org/10.1038/nrgastro.2015.31
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.31
